Loading
SkinVision is a health technology company based in Amsterdam, Netherlands, founded in 2012. The company focuses on early skin cancer detection through its clinically validated mobile application, which utilizes artificial intelligence and dermatologist expertise. SkinVision's mission is to reduce skin cancer-related deaths by 50%, aiming to save 250,000 lives by enhancing access to skin health awareness and care. The SkinVision app allows users to analyze photos of moles and skin spots to assess the risk of skin cancer. It achieves a sensitivity of over 90% in detecting skin cancer, helping users identify early signs of melanoma, squamous cell carcinoma, basal cell carcinoma, and precancerous actinic keratosis. The app is available worldwide on iOS and Android, except in the United States and Canada, where the company is working on trials to improve access to dermatology care. SkinVision also operates as a digital dermatology clinic, providing self-skin exams and monitoring capabilities, and has established partnerships with healthcare providers to enhance skin healthcare access.